Deoxyribonuclease structure
|
Common Name | Deoxyribonuclease | ||
---|---|---|---|---|
CAS Number | 9003-98-9 | Molecular Weight | N/A | |
Density | 100 g/mL at 20 °C | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of DeoxyribonucleaseDeoxyribonuclease (DNase) is an enzyme that degrade DNA, it plays a key role in the cleavage of extracellular DNA is crucial for limiting the inflammatory response and maintaining homeostasis. Exogenous deoxyribonuclease shows beneficial effects in inflammatory diseases and cancer[1]. |
Name | Deoxyribonuclease |
---|---|
Synonym | More Synonyms |
Description | Deoxyribonuclease (DNase) is an enzyme that degrade DNA, it plays a key role in the cleavage of extracellular DNA is crucial for limiting the inflammatory response and maintaining homeostasis. Exogenous deoxyribonuclease shows beneficial effects in inflammatory diseases and cancer[1]. |
---|---|
Related Catalog | |
In Vivo | Deoxyribonuclease (0.1 U; i.p.; once daily for 3 days) inhibits liver metastasis, besides results in a greater prolongation of the survival period by combining surgical removal of the primary tumour mass[1]. Animal Model: Female BALB/c x DBA/2 mice with murine tumour L5178Y-ML cells subcutaneous injection[1] Dosage: 0.1 U per mouse Administration: Intravenous injection; 0.1 U; once daily for three days Result: Reduced liver weight from 2.26 to 1.55 g, affected the intensity of liver metastasis, reduced the numbers and sizes of metastatic and affected tumour cell arrest. Animal Model: Female BALB/c x DBA/2 mice with murine tumour and surgical removal of subcutaneous tumours[1] Dosage: 0.1 U per mouse Administration: Intravenous injection; 0.1 U; once daily for 3 days either before or after primary tumour removal Result: Significantly prolongated survival after tumour cell inoculation compared to the untreated group. |
Density | 100 g/mL at 20 °C |
---|---|
Appearance of Characters | solution (clear, colorless) | white |
Storage condition | −20°C |
Water Solubility | Soluble in 0.15 M sodium chloride (5.0mg/L) clear. |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | 23-24/25-22 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | RF0750000 |
ADAM12-directed ectodomain shedding of E-cadherin potentiates trophoblast fusion.
Cell Death Differ. 22 , 1970-84, (2015) Trophoblasts, placental cells of epithelial lineage, undergo extensive differentiation to form the cellular components of the placenta. Trophoblast progenitor cell differentiation into the multinuclea... |
|
ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenation.
Autophagy 11 , 1308-25, (2015) Recent studies have shown that the phosphorylation and dephosphorylation of ULK1 and ATG13 are related to autophagy activity. Although ATG16L1 is absolutely required for autophagy induction by affecti... |
|
Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is downregulated by autophagy.
Autophagy 11(1) , 166-82, (2015) The nucleotide-binding domain, leucine-rich repeat containing family caspase recruitment domain containing 4 (NLRC4) inflammasome can be activated by pathogenic bacteria via products translocated thro... |
Alkaline DNase |
Alkaline deoxyribonuclease |
DNA depolymerase |
DNA endonuclease |
DNA nuclease |
DNAase |
DNase |
Deoxyribonuclease A |
Deoxyribonuclease I |
Deoxyribonucleic phosphatase |
Desoxyribonuclease |
Dornase |
Pancreatic deoxyribonuclease |
Pancreatic dornase |